These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

152 related articles for article (PubMed ID: 8661487)

  • 1. Effect of bisphosphonates on the increase in bone resorption induced by a low calcium diet.
    Antic VN; Fleisch H; Mühlbauer RC
    Calcif Tissue Int; 1996 Jun; 58(6):443-8. PubMed ID: 8661487
    [TBL] [Abstract][Full Text] [Related]  

  • 2. BM 21.0955, a potent new bisphosphonate to inhibit bone resorption.
    Mühlbauer RC; Bauss F; Schenk R; Janner M; Bosies E; Strein K; Fleisch H
    J Bone Miner Res; 1991 Sep; 6(9):1003-11. PubMed ID: 1838661
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Reduction of instability-induced bone resorption using bisphosphonates: high doses are needed in rats.
    Astrand J; Aspenberg P
    Acta Orthop Scand; 2002 Jan; 73(1):24-30. PubMed ID: 11928907
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Bisphosphonates alendronate and ibandronate inhibit artery calcification at doses comparable to those that inhibit bone resorption.
    Price PA; Faus SA; Williamson MK
    Arterioscler Thromb Vasc Biol; 2001 May; 21(5):817-24. PubMed ID: 11348880
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Bisphosphonates: preclinical aspects and use in osteoporosis.
    Fleisch HA
    Ann Med; 1997 Feb; 29(1):55-62. PubMed ID: 9073324
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Antagonistic effects of different classes of bisphosphonates in osteoclasts and macrophages in vitro.
    Frith JC; Rogers MJ
    J Bone Miner Res; 2003 Feb; 18(2):204-12. PubMed ID: 12568397
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Acute effects of bisphosphonates on new and traditional markers of bone resorption.
    Pedrazzoni M; Alfano FS; Gatti C; Fantuzzi M; Girasole G; Campanini C; Basini G; Passeri M
    Calcif Tissue Int; 1995 Jul; 57(1):25-9. PubMed ID: 7671161
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Inhibition of bone resorption by the bisphosphonate BM 21.0955 is not associated with an alteration of the renal handling of calcium in rats infused with parathyroid hormone-related protein.
    Rizzoli R; Caverzasio J; Bauss F; Bonjour JP
    Bone; 1992; 13(4):321-5. PubMed ID: 1389572
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effects of alendronate on plasma calcium levels, urinary calcium excretion, and bone resorption markers in normal rats: comparison with elcatonin, synthetic eel calcitonin.
    Azuma Y; Chokki M; Ohta T; Kiyoki M
    Endocrinology; 1996 Jun; 137(6):2586-92. PubMed ID: 8641213
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Clodronate stimulates bone formation as well as inhibits bone resorption and increases bone mineral density in rats fed a low-calcium diet.
    Horie D; Takahashi M; Aoki K; Ohya K
    J Med Dent Sci; 2003 Mar; 50(1):121-32. PubMed ID: 12715928
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Bisphosphonates in prostate carcinoma.
    Adami S
    Cancer; 1997 Oct; 80(8 Suppl):1674-9. PubMed ID: 9362435
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The bisphosphonate ibandronate, given daily as well as discontinuously, decreases bone resorption and increases calcium retention as assessed by 45Ca kinetics in the intact rat.
    Fleisch H
    Osteoporos Int; 1996; 6(2):166-70. PubMed ID: 8704357
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Ibandronate.
    Dooley M; Balfour JA
    Drugs; 1999 Jan; 57(1):101-8; discussion 109-10. PubMed ID: 9951955
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Bone resorption in orthotopic and heterotopic bone of dichloromethylene bisphosphonate-treated rats.
    Nilsson OS; Bauer HC; Brosjö O; Törnkvist H
    J Orthop Res; 1990 Mar; 8(2):213-9. PubMed ID: 2137534
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Bisphosphonates act on rat bone resorption through the mediation of osteoblasts.
    Sahni M; Guenther HL; Fleisch H; Collin P; Martin TJ
    J Clin Invest; 1993 May; 91(5):2004-11. PubMed ID: 8486770
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect of a single infusion of alendronate in malignant hypercalcaemia: dose dependency and comparison with clodronate.
    Rizzoli R; Buchs B; Bonjour JP
    Int J Cancer; 1992 Mar; 50(5):706-12. PubMed ID: 1531972
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Inhibition of bone resorption by bisphosphonates: interactions between bisphosphonates, osteoclasts, and bone.
    Flanagan AM; Chambers TJ
    Calcif Tissue Int; 1991 Dec; 49(6):407-15. PubMed ID: 1840176
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effects of an oral bisphosphonate and three intravenous bisphosphonates on several cell types in vitro.
    Jung J; Park JS; Righesso L; Pabst AM; Al-Nawas B; Kwon YD; Walter C
    Clin Oral Investig; 2018 Sep; 22(7):2527-2534. PubMed ID: 29388023
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Bisphosphonates for prevention of postmenopausal osteoporosis.
    Ravn P
    Dan Med Bull; 2002 Feb; 49(1):1-18. PubMed ID: 11894721
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Bisphosphonates and bone resorption: effects on collagenase and lysosomal enzyme excretion.
    Delaissé JM; Eeckhout Y; Vaes G
    Life Sci; 1985 Dec; 37(24):2291-6. PubMed ID: 2999548
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.